NVAX Soars on Coronavirus Vaccine Deal with U.S. Government

The equity is up an unheard of 2,664.3% year-to-date

Digital Content Manager
Jul 7, 2020 at 11:38 AM
facebook X logo linkedin

The shares of Novavax, Inc. (NASDAQ: NVAX) are up 24.2% at $98.72 this morning, after the U.S. government awarded the drug development company $1.6 billion to cover testing, commercialization, and manufacturing of a potential coronavirus vaccine. The investment is part of a White House program that seeks to accelerate access to COVID-19 treatments, and deliver 100 million vaccines by January 2021. 

The race for a coronavirus treatment has lifted NVAX up on the charts. Though shares have been on the rise since May, today's news boosted the equity to a nearly four-year high of $111.77. The stock's 10-day moving average has served as support over the past few weeks, containing most of NVAX's pullbacks late last week. Longer term, the equity is performing incredibly well, and sports a jaw-dropping 2,378.2% lead this year. 

Analysts were mostly optimistic toward NVAX, with five of the seven in coverage sporting a "strong buy," and only two carrying a tepid "hold." Meanwhile, the consensus 12-month price target of $86.25 is a significant 12.34% discount to current levels, meaning price-target hikes could be on the horizon. Short sellers are coming in droves, however. Short interest is up 10.2% in the last two reporting periods, and the 8.11 million shares sold short make up a hefty 34.5% of NVAX's available float.

That sentiment is echoed in the options pits, where the stock's Schaeffer's put/call open interest ratio (SOIR) comes in at 1.17. This ranks in the 94th percentile of readings from the past year -- highlighting a strong appetite for puts over calls among short-term speculators.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI